BMT Group of Georgia — Atlanta, Georgia

BMT Group of Georgia is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

BMT Group of Georgia has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Graft Versus Host Disease, Acute, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma.

Sponsors: Cynata Therapeutics Limited, Medical College of Wisconsin.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for BMT Group of Georgia?

BMT Group of Georgia has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has BMT Group of Georgia conducted?

BMT Group of Georgia has 2 clinical trials on record, with 1 currently active. Their work covers Graft Versus Host Disease, Acute, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma.

Is BMT Group of Georgia accredited by Crixeo Health?

BMT Group of Georgia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about BMT Group of Georgia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.